• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Nkar­ta drops an­oth­er can­cer pro­gram as it leans in­to au­toim­mune dis­ease

7 months ago
R&D

Athi­ra gives up on lead Alzheimer’s drug, switch­es tack to ALS

7 months ago
R&D

Pfiz­er to in­vest $1B in Chi­na over next five years — re­ports

7 months ago
Financing
China

Se­nior As­traZeneca ex­ec de­tained in Chi­na amid wider in­ves­ti­ga­tion

7 months ago
People
China

Stephen Squin­to's JPM life sci­ences team is rais­ing a new fund for lat­er-stage com­pa­nies

7 months ago
Financing
Startups

Soft RSV sales re­veal a vac­cine mar­ket fail­ing to catch post-Covid mo­men­tum

7 months ago
Pharma
FDA+

FDA seeks to pull OTC nasal de­con­ges­tant in­gre­di­ent due to lack of ef­fi­ca­cy

7 months ago
Pharma
FDA+

Co­herus restarts biosim­i­lar sup­ply af­ter de­lays; No­vavax ends Covid vac­cine deal with UK

7 months ago
Manufacturing

Gen­mab chops ear­ly can­cer prospects to pri­or­i­tize Phase 3 projects

7 months ago
R&D
Pharma

Au­rinia cuts near­ly half of its work­force in sec­ond round of lay­offs this year

7 months ago
R&D

Geron’s roy­al­ty deal; Minghui’s new VEGF bis­pe­cif­ic da­ta

7 months ago
News Briefing

De­nali teas­es ear­ly da­ta for en­zyme re­place­ment ther­a­py in rare dis­ease

7 months ago
R&D

Q&A: Demis Has­s­abis talks win­ning the No­bel Prize, build­ing an AI biotech sans lab, and Trump’s po­ten­tial im­pact

7 months ago
People
AI

Avid Bioser­vices to be sold to pri­vate eq­ui­ty firms for $1.1B

7 months ago
Deals
Manufacturing

How Men­lo Ven­tures thinks AI in health tech is go­ing to be com­modi­tized

7 months ago
AI
Health Tech

Gilead beats Covid drug sales fore­casts, takes $1.75B hit on Trodelvy study fail

7 months ago
R&D
Pharma

Ar­cus backs TIG­IT com­bo by of­fer­ing glimpse at pos­i­tive da­ta from axed tri­al

7 months ago
R&D

Joe Jimenez's lat­est Adi­tum com­pa­ny lines up T cell en­gager from Chi­na

7 months ago
Startups
Deals

Mod­er­na re­ports slow start to RSV sales as Ban­cel steps back from com­mer­cial role

7 months ago
People
Pharma

Sarep­ta dis­con­tin­ues work on next-gen ex­on-skip­ping drug for Duchenne

7 months ago
R&D

Cal­i­for­nia vot­ers say yes to re­stric­tions around 340B spend­ing

7 months ago
Pharma
FDA+

GSK CEO Em­ma Walm­s­ley on the new Trump ad­min­is­tra­tion, trust, AI and Chi­na

7 months ago
People
China

Stud­ies show how once-ob­scure DNA cir­cles dri­ve can­cer, and maybe even how to stop them

7 months ago
Discovery

CVS names Aet­na head, plans more phar­ma­cy clo­sures as new CEO takes over

7 months ago
People
Pharma
First page Previous page 79808182838485 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times